Literature DB >> 18063753

Hls5 regulated erythroid differentiation by modulating GATA-1 activity.

Raelene Endersby1, Ian J Majewski, Louise Winteringham, Jennifer G Beaumont, Amy Samuels, Robin Scaife, Esther Lim, Merlin Crossley, S Peter Klinken, Jean-Philippe Lalonde.   

Abstract

Hemopoietic lineage switch (Hls) 5 and 7 were originally isolated as genes up-regulated during an erythroid-to-myeloid lineage switch. We have shown previously that Hls7/Mlf1 imposes a monoblastoid phenotype on erythroleukemic cells. Here we show that Hls5 impedes erythroid maturation by restricting proliferation and inhibiting hemoglobin synthesis; however, Hls5 does not influence the morphology of erythroid cells. Under the influence of GATA-1, Hls5 relocates from cytoplasmic granules to the nucleus where it associates with both FOG-1 and GATA-1. In the nucleus, Hls5 is able to suppress GATA-1-mediated transactivation and reduce GATA-1 binding to DNA. We conclude that Hls5 and Hls7/Mlf1 act cooperatively to induce biochemical and phenotypic changes associated with erythroid/myeloid lineage switching.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063753     DOI: 10.1182/blood-2007-04-085746

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma.

Authors:  Z Chen; Z Wang; W Guo; Z Zhang; F Zhao; Y Zhao; D Jia; J Ding; H Wang; M Yao; X He
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

2.  Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif.

Authors:  E R Yassin; A M Abdul-Nabi; A Takeda; N R Yaseen
Journal:  Leukemia       Date:  2010-03-25       Impact factor: 11.528

3.  Tripartite motif containing 35 contributes to the proliferation, migration, and invasion of lung cancer cells in vitro and in vivo.

Authors:  Jingtao Zhang; Zihao Xu; Boyao Yu; Jiatang Xu; Bentong Yu
Journal:  Biosci Rep       Date:  2020-04-30       Impact factor: 3.840

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.